TRLV · NYSE · Drug Manufacturers - Specialty & Generic

Trulieve Cannabis (TRLV)

Vertically integrated medical-cannabis cultivator, manufacturer, and dispensary operator.

$12.69
vs last close+0.21 (+1.72%)

Something off on this page? Send us feedback.

Next report
Nov 6, 26
in 44 days
EPS estimate
$0.09
Revenue estimate
$221.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.31−$0.17−$0.07−$0.14−$0.22$0.01−$2.11Pending
Estimate−$0.22−$0.07−$0.06−$0.08−$0.07−$0.01$0.06$0.09
Surprise−40.6%−131.7%−15.9%−65.5%−196.2%+170.8%−3,616.7%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$301.0M$297.8M$302.1M$288.2M$293.1M$286.8M$271.0MPending
Estimate$292.5M$294.3M$301.5M$287.5M$298.3M$284.7M$268.5M$221.9M
Surprise+2.9%+1.2%+0.2%+0.3%−1.7%+0.7%+0.9%

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2028$0.00
Sep 2028$0.00
Jun 2028$0.00
Mar 2028$0.00
Dec 2027$0.14
Sep 2027$0.14
Jun 2027$0.14
Mar 2027$0.13
Dec 2026$0.10
Nov 2026$0.09
Aug 2026$0.06−$2.11−3,616.7%
May 2026−$0.01$0.01+170.8%
Feb 2026−$0.07−$0.22−196.2%
Nov 2025−$0.08−$0.14−65.5%
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024

The latest year is open to everyone — the 5 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2028$0.00$251.3M
Sep 2028$0.00$257.4M
Jun 2028$0.00$207.9M
Mar 2028$0.00$194.9M
Dec 2027$0.14$239.9M
Sep 2027$0.14$235.8M
Jun 2027$0.14$235.4M
Mar 2027$0.13$231.3M
Dec 2026$0.10$227.7M
Nov 6, 2026$0.09$221.9M
Aug 6, 2026$0.06−$2.11−3,616.7%$268.5M$271.0M+0.9%+6.6%
May 7, 2026−$0.01$0.01+170.8%$284.7M$286.8M+0.7%−4.9%
Feb 26, 2026−$0.07−$0.22−196.2%$298.3M$293.1M−1.7%+1.6%
Nov 5, 2025−$0.08−$0.14−65.5%$287.5M$288.2M+0.3%+2.3%
Aug 6, 2025
May 7, 2025
Feb 27, 2025
Nov 5, 2024
Aug 6, 2024

The latest year is open to everyone — the 5 quarters behind it read with an account.